Titan Pharmaceuticals
TTNP
#10775
Rank
C$8.63 M
Marketcap
C$6.49
Share price
-3.76%
Change (1 day)
19.59%
Change (1 year)

Earnings for Titan Pharmaceuticals (TTNP)

Earnings in 2025 (TTM): -C$3.92 Million

According to Titan Pharmaceuticals 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$6.63 Million, an increase over its 2023 earnings that were of -C$7.85 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Titan Pharmaceuticals from 1995 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$3.92 Million-40.96%
2024 -C$6.63 Million-15.5%
2023 -C$7.85 Million-45.43%
2022 -C$14.38 Million16.29%
2021 -C$12.37 Million-907.36%
2020 C$1.53 M-106.6%
2019 -C$23.19 Million82.4%
2018 -C$12.71 Million-36.93%
2017 -C$20.16 Million-378.62%
2016 C$7.23 M-145.53%
2015 -C$15.89 Million369.37%
2014 -C$3.39 Million-125.9%
2013 C$13.06 M-177.74%
2012 -C$16.81 Million13.59%
2011 -C$14.8 Million74.37%
2010 -C$8.49 Million3.61%
2009 -C$8.2 Million
2007 -C$25.97 Million12.08%
2006 -C$23.17 Million-28.65%
2005 -C$32.47 Million-10.03%
2004 -C$36.09 Million-6.08%
2003 -C$38.43 Million-14.76%
2002 -C$45.08 Million32.52%
2001 -C$34.02 Million27.55%
2000 -C$26.67 Million62.5%
1999 -C$16.42 Million4.04%
1998 -C$15.78 Million49.33%
1997 -C$10.57 Million-27.88%
1996 -C$14.65 Million13.04%
1995 -C$12.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.59 B-926,267.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.23 B-562,809.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-C$0.18 Billion 4,217.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.11 B-3,090.94%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-C$16.91 Million 327.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.41 Billion 10,144.78%๐Ÿ‡บ๐Ÿ‡ธ USA